Levalbuterol hydrochloride

盐酸左沙丁胺醇

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameLevalbuterol hydrochloride
Drug Alias Name左沙丁胺醇盐酸盐levosalbutamolumLevosalbutamol hydrochloride(R)-salbutamol hydrochloride(R)-albuterol hydrochloride +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsBronchoconstrictionRespiratory InsufficiencyTransient Tachypnea of the Newborn +[9] 
Global Approved IndicationsBronchial Spasm
Approved Indications in ChinaBronchial Spasm
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of WarsawJoincare Pharmaceutical Group Industry Co Ltd
Inactive CompaniesHikmaSumitomo Pharma America Inc
Active IndicationsRespiratory InsufficiencyTransient Tachypnea of the NewbornPulmonary Disease, Chronic Obstructive +[6] 
Inactive IndicationsBronchoconstrictionAsthma, Exercise-InducedRespiratory Tract Diseases

Other Information

ATC CodeR03CC
Related LinksWikipediaDrugBankKEGG